Ammonium, hexamethylenebis[triethyl-, dibromide | CAS:7072-43-7

We serve Ammonium, hexamethylenebis[triethyl-, dibromide CAS:7072-43-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Ammonium, hexamethylenebis[triethyl-, dibromide

Chemical Name:Ammonium, hexamethylenebis[triethyl-, dibromide
CAS.NO:7072-43-7
Synonyms:Ammonium, hexamethylenebis[triethyl-, dibromide
N-acetylperhydroazepine
1-acetyl-azepane
N-acetylhexahydroazepine
1-Acetyl-hexahydro-azepin
1-Acetylhexahydro-1H-azepine
 
Physical and Chemical Properties:
Molecular Formula C18H42BrN2+
Molecular Weight 366.44300
 
Specification:
Appearance:White to off-white crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Phase transfer catalysts, molecular sieve template agent, electronic industry, etc.



Contact us for information like Ammonium, hexamethylenebis[triethyl-, dibromide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Acetylhexahydro-1H-azepine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Acetyl-hexahydro-azepin Use and application,1-Acetyl-hexahydro-azepin technical grade,usp/ep/jp grade.


Related News: The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.3-fluoroaniline manufacturer In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate supplier In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.2-Chloro-5-nitroanisole vendor In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies.